SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (NASDAQ: PRCT), a surgical robotics global leader, is pleased to announce that the National Institute for Health ...
For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...
(HealthDay News) — The Aquablation water-based surgical procedure is safe and effective for use with enlarged prostates compared with laser surgery, according to a study presented at the 40th annual ...
SAN JOSE, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company dedicated to advancing patient care through ...
Two interventions to treat large prostates produced similar symptom relief but had different effects on prostate volume and different adverse event profiles, a large randomized trial showed. Baseline ...
SAN JOSE, Calif. - PROCEPT BioRobotics Corporation (NASDAQ:PRCT), a $3.18 billion market cap company specializing in surgical robotics, announced today that its Aquablation therapy has shown similar ...
(MENAFN- GlobeNewsWire - Nasdaq) SAN JOSE, Calif., Oct. 12, 2023 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (NASDAQ: PRCT), a surgical robotics global leader, is pleased to announce that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback